Overview

A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to compare the safety of DFD01 Spray to Comp01 Lotion for topical treatment of moderate plaque psoriasis and to compare the efficacy of DFD01 Spray to Placebo Spray for topical treatment of moderate plaque psoriasis after 28 days of treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Encore Dermatology, Inc.
Promius Pharma, LLC
Collaborator:
Prosoft Clinical